Bio-Thera And Stada Joins Forces On Golimumab, With Up To $160m On The Table

Stada Looking To Scale Up In EU Immunology; Appreciates Bio-Thera’s US Approvals

 
• By Dean Rudge
  
aorpixza/Shutterstock.com
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products